Unlike TP53, mutations are uncommon in TP63, but it is overexpressed in a subset of basal cell and squamous cell carcinomas of the head and neck, due to chromosomal amplification, and elevated levels of TP63 RNA have been reported in a number of different tumour types (reviewed in [4]). This evidence concerns the gene TP63 and squamous cell carcinoma.